USA Current Affairs - 2020
Category Wise PDF Compilations available at This Link
President Donald Trump has vetoed the resolution from the US Congress which directed him to end U.S. support for the civil war in Yemen.
Why the President has vetoed the Congress Resolution?
President trump has stated the following reasons for vetoing the US Congress resolution:
- Yemen is at a breaking point as 10 million people on the brink of famine. There are more than 100 civilian casualties per week, and Yemenis are more likely to be killed at home than in any other structure.
- U.S. support for the war between the Saudi-backed Yemeni government and Iran-aligned Houthi rebels was necessary to protect the safety of the more than 80,000 Americans who reside in certain coalition countries.
President Trump has called the resolution as an unnecessary and a dangerous attempt to weaken his constitutional authorities. He further stressed that the resolution endangers the lives of American citizens and brave service members, both today and in the future.
It was the second veto during his presidency, earlier he had vetoed a congressional resolution which was aimed to reverse the border emergency President Trump had declared in order to secure more funding for his wall between the United States and Mexico.
Tags: Iran • Mexico • President Trump • Saudi Arabia • US Congress
The report by the Center for Disease Dynamics, Economics & Policy (CDDEP) in the US has made the following observations about the antibiotics and their access:
- Majority of the world’s annual 5.7 million antibiotic-treatable deaths occur in low- and middle-income countries.
- In low- and middle-income countries the mortality burden from treatable bacterial infections far exceeds the estimated annual 700,000 deaths from antibiotic-resistant infections.
- Even after the discovery of a new antibiotic, regulatory hurdles and substandard health facilities delay or altogether prevent widespread market entry and drug availability.
- Of 21 new antibiotics which entered the market between 1999 and 2014, only less than five were registered in most countries in sub-Saharan Africa. This indicates that the availability of a certain drug does not ensure its accessibilities in countries that require them the most.
- Health facilities in many low- and middle-income countries are substandard and lack staff who are properly trained in administering antibiotics.
- Lack of access to antibiotics is killing more people currently than does antibiotic resistance.
The irrational use of antibiotics and poor antimicrobial stewardship lead to treatment failures. This further propagates the spread of drug resistance which, in turn, further narrows the available array of effective antibiotics.
Research and development for new antimicrobials, vaccines, and diagnostic tests have slowed down since the 1960s as a profitable investment in this area is limited by low sales volumes, short duration of treatment, competition with established products and less expensive generics, and the possibility that resistance will rapidly emerge.